SPOTLIGHT: Say goodbye to Big Pharma's gilded age

Yes, generic competition has become something of a mantra in the drug industry. But we're going to start the chant again, because The Wall Street Journal took a close look at just how much revenue the industry will be lost over the next few years--and posits that Big Pharma's gilded age will soon be history. Report